Oncology Drug Prices In US, Europe Misaligned With Clinical Value Assessments

 
• By Cathy Kelly

Study's finding is somewhat surprising for Europe, given the greater national involvement in drug prices in the region; ASCO and ESMO value frameworks don't appear to drive oncology pricing decisions regardless of the reimbursement system.

production line
Reseachers Measure Cancer Drug Prices In US And Europe

More from Health Technology Assessment

More from Market Access